Abiomed, Inc.ABMDNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+20.5%
5Y CAGR+19.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+20.5%/yr
vs +27.0%/yr prior
5Y CAGR
+19.7%/yr
Consistent
Acceleration
-6.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2022 | $163.40M | +34.1% |
| 2021 | $121.88M | +23.4% |
| 2020 | $98.76M | +5.6% |
| 2019 | $93.50M | +24.2% |
| 2018 | $75.30M | +13.4% |
| 2017 | $66.39M | +33.4% |
| 2016 | $49.76M | +38.3% |
| 2015 | $35.97M | +17.1% |
| 2014 | $30.71M | +19.7% |
| 2013 | $25.65M | - |